This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Chinese biopharma specialist Hanbon navigates IPO journey amid patent conflicts with Cytiva

By MLex Staff ( August 16, 2024, 07:45 GMT | Insight) -- In what is a pivotal moment for it, a Chinese chromatography-instruments company that is seeking an initial public offering is striving to dispel a shadow cast by its patent disputes with global life sciences business Cytiva. The planned IPO is aimed at securing funding totaling 980 million yuan ($136 million). Jiangsu Hanbon Science and Technology, in a detailed response to the Shanghai Stock Exchange, addressed queries covering its ongoing patent conflicts with Cytiva as well as the innovative nature of its core technologies.In what is a pivotal moment for it, a Chinese chromatography-instruments company that is seeking an initial public offering is striving to dispel a shadow cast by its patent disputes with global life sciences business Cytiva. The planned IPO is aimed at securing funding totaling 980 million yuan ($136 million). Jiangsu Hanbon Science and Technology, in a detailed response to the Shanghai Stock Exchange, addressed queries covering its ongoing patent conflicts with Cytiva as well as the innovative nature of its core technologies....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections